WO2011084514A9 - Procédés et compositions pour traiter une complication associée à la malaria - Google Patents
Procédés et compositions pour traiter une complication associée à la malaria Download PDFInfo
- Publication number
- WO2011084514A9 WO2011084514A9 PCT/US2010/060565 US2010060565W WO2011084514A9 WO 2011084514 A9 WO2011084514 A9 WO 2011084514A9 US 2010060565 W US2010060565 W US 2010060565W WO 2011084514 A9 WO2011084514 A9 WO 2011084514A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- malaria
- compositions
- treating
- methods
- related complication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28703709P | 2009-12-16 | 2009-12-16 | |
| US61/287,037 | 2009-12-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2011084514A2 WO2011084514A2 (fr) | 2011-07-14 |
| WO2011084514A9 true WO2011084514A9 (fr) | 2011-11-10 |
Family
ID=44306039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2010/060565 Ceased WO2011084514A2 (fr) | 2009-12-16 | 2010-12-15 | Procédés et compositions pour traiter une complication associée à la malaria |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2011084514A2 (fr) |
-
2010
- 2010-12-15 WO PCT/US2010/060565 patent/WO2011084514A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011084514A2 (fr) | 2011-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2419670B8 (fr) | Procédé de distribution et compositions | |
| EP2475632A4 (fr) | Composés de monochlorotrifluoropropène et compositions et procédés associés | |
| ZA201204841B (en) | Rebaudioside a composition and method for puriying rebaudioside a | |
| WO2010123759A9 (fr) | Compositions et procédés pour traiter des brûlures | |
| EP2429584A4 (fr) | Procédés et compositions de traitement | |
| GB0903299D0 (en) | Composition and methods | |
| GB0912468D0 (en) | Composition and method | |
| WO2011057220A9 (fr) | Compositions et méthodes pour traiter les lymphomes | |
| GB0901494D0 (en) | Compositions and Methods | |
| GB0901667D0 (en) | Composition and method | |
| WO2011084514A9 (fr) | Procédés et compositions pour traiter une complication associée à la malaria | |
| HK1166283A (en) | Methods and compositions for treating leukemia | |
| AU2008900271A0 (en) | Methods and compositions for treating a diabetic complication | |
| HK1164745A (en) | Methods and compositions for treating neuropathies | |
| AU2008905187A0 (en) | Methods and compositions for treating a hormonal condition | |
| HK1168281A (en) | Methods and compositions for treating lupus | |
| AU2014200650C1 (en) | Anti-CXCR1 compositions and methods | |
| HK1171462A (en) | Compositions and methods for treating aspergillosis | |
| AU2009900437A0 (en) | Method three | |
| AU2009904598A0 (en) | Method three | |
| AU2008905185A0 (en) | Methods and compositions for preparing hormone-depleted surem | |
| AU2009902910A0 (en) | Dermaportation Method | |
| AU2009901427A0 (en) | Method | |
| AU2010901721A0 (en) | Method and composition | |
| GB0908956D0 (en) | Method and composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10842555 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 10842555 Country of ref document: EP Kind code of ref document: A1 |